Brcic et al. [9] found that low PD-L1 expression in tumor cells correlates with better survival rates, while high PD-L1 expression (over 10%) is linked to significantly reduced overall survival, regardless of histology, gender, age, or treatment stage. Here, CD274 is linked to neoplasm.